Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model

This publication has 29 references indexed in Scilit:

• Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: Results of the randomized investigation by the thoraxcenter of antisense dna using local delivery and ivus after coronary stenting (ITALICS) trial
  Journal of the American College of Cardiology, 2002
• COMPARISON OF EFFICACY OF ANTISENSE OLIGOMERS DIRECTED TOWARD TNF-α IN HELPER T AND MACROPHAGE CELL LINES
  Cytokine, 1997
• Fluorescence Microscopic Comparison of the Binding of Phosphodiester and Phosphorothioate (Antisense) Oligodeoxyribonucleotides to Subcellular Structures, Including Intermediate Filaments, the Endoplasmic Reticulum, and the Nuclear Interior
  Antisense and Nucleic Acid Drug Development, 1997
• A Specificity Comparison of Four Antisense Types: Morpholino, 2′-O-Methyl RNA, DNA, and Phosphorothioate DNA
  Antisense and Nucleic Acid Drug Development, 1997
• Morpholino and Phosphorothioate Antisense Oligomers Compared in Cell-Free and In-Cell Systems
  Antisense and Nucleic Acid Drug Development, 1997
• Efficacy of Morpholino-modified Antisense Oligomers Directed against Tumor Necrosis Factor-α mRNA
  Published by Elsevier ,1996
• Resistance of Morpholino Phosphorodiamidate Oligomers to Enzymatic Degradation
  Antisense and Nucleic Acid Drug Development, 1996
• Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.
  Journal of Clinical Investigation, 1994
• Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
  Science, 1993
• Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
  Nature, 1992